Good afternoon and thank you for joining Zevra's First Quarter 2025 Financial Results and Corporate Update Conference Call. Today's call is being recorded, and will be available via the Investor ...

Nichol Ochsner; Vice President of Investor Relations & Corporate Communications; Zevra Therapeutics Inc. Neil Mcfarlane; President, Chief Executive Officer, Director ...

Soligenix, Inc.  (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The United States and Britain are expected to announce a trade deal Thursday that will lower the burden of President Donald ...

Q2 2025 Results Conference Call May 8, 2025 9:00 AM ETCompany ParticipantsJessica Batt - Vice President of Investor Relations ...

Served on Celgene's Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos” or the "Company”), today announced its 2025 first quarter business ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2025 and recent business ...

Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Isr ...

Nine employees at One Medical, owned by Amazon, allegedly accessed the medical records of a deceased patient without authorization following the filing of a wrongful death lawsuit by the patient’s ...